Showing results (1511-1520 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|September 14, 2020
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosisMartina Barone, Lucia Catani, Francesca Ricci, et al.
Oncoimmunology|September 14, 2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responsesPeng Liu, Liwei Zhao, Gladys Ferrere, et al.
Oncoimmunology|September 14, 2020
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosisOliver Kepp, Peng Liu, Liwei Zhao, et al.
Oncoimmunology|September 14, 2020
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?Shashi Gujar, Jonathan G Pol, Youra Kim, et al.
Oncoimmunology|September 14, 2020
Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete responseAndromachi Kotsafti, Melania Scarpa, Francesco Cavallin, et al.
Oncoimmunology|September 14, 2020
Metastasis immune-based scores predict patient survivalBernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, et al.
Oncoimmunology|October 26, 2020
Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expressionM Pötzsch, E Berg, M Hummel, et al.
Oncoimmunology|October 26, 2020
Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approachAna María Hurtado López, Tzu Hua Chen-Liang, María Zurdo, et al.
Oncoimmunology|October 26, 2020
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinomaAlexandra Drakaki, Preet K Dhillon, Heather Wakelee, et al.
Oncoimmunology|October 26, 2020
Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patientsSuresh Gopi Kalathil, Katy Wang, Alan Hutson, et al.
Pageof 380